The compound, SB-0110, was tested in rodent and non-human primate models of Parkinson’s disease during preclinical tests.

Millions of people living with Parkinson’s disease may soon have a new treatment option on the table. AbbVie has submitted a ...

New clinical data from the STEM-PD Phase I/II clinical trial have been presented at the ISSCR 2026 Annual Meeting. The study ...

Dopamine agonists such as pramipexole, ropinirole, rotigotine, and apomorphine have long been recommended as initial therapy for younger patients with Parkinson’s disease, typically those younger than ...

For many people with Parkinson's disease, the body stops moving the way it used to. A hand may tremble at rest. Muscles may ...

A novel biodegradable gel delivers Parkinson’s medications via a single weekly shot, potentially replacing current regimens of multiple pills per day. The corresponding study was published in Drug ...

Serina Therapeutics is showcasing its innovative drug candidate SER-252, which aims to provide continuous symptom relief for Parkinson’s disease, addressing limitations of current treatments. The ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. In an interview for Healio's Clinical ...

A Yale researcher told Newsweek one newly identified Parkinson's target is already being tested in trials.

Disease progression in people with Parkinson's disease can be accurately monitored using sensors, removing some of the ...